A novel flow through diffusion cell for assessing drug transport across the buccal mucosa in vitro

Maria Lucia Ardhani Dwi Lestari, Joseph Nicolazzo, Barrie Charles Finnin

Research output: Contribution to journalArticleResearchpeer-review

13 Citations (Scopus)

Abstract

A novel flow through (FT) diffusion cell for assessing the permeability of compounds across the buccal mucosa was designed. porcine buccal mucosa was mounted between two chambers with flow through capacity in both the donor and receptor chambers. The permeability of caffeine (CAF), triamcinolone acetonide (TAC), and estradiol was determined over 4 h and flux values were compared to those obtained using a modified Ussing chamber (MUC). No significant differences in the flux of each probe compound were observed using either the MUC or the novel FT cell. The design of the FT cell allowed for monitoring appearance of receptor solution within the donor chamber during the initial equilibration period, allowing for visual inspection of tissue integrity. These permeability studies demonstrate that this FT cell is a suitable alternative model for assessing drug permeability across the buccal mucosa, without the limitations associated with the static MUC. This novel model was then utilized to determine whether salmeterol xinafoate (SX) could permeate the buccal mucosa at concentrations expected in the oral cavity following inhalation. Concentration-dependent studies demonstrated that SX permeates the buccal mucosa via passive diffusion and that oral mucosal absorption may contribute significantly to the overall systemic exposure of inhaled SX.
Original languageEnglish
Pages (from-to)4577 - 4588
Number of pages12
JournalJournal of Pharmaceutical Sciences
Volume98
Issue number12
Publication statusPublished - 2009

Cite this

Lestari, Maria Lucia Ardhani Dwi ; Nicolazzo, Joseph ; Finnin, Barrie Charles. / A novel flow through diffusion cell for assessing drug transport across the buccal mucosa in vitro. In: Journal of Pharmaceutical Sciences. 2009 ; Vol. 98, No. 12. pp. 4577 - 4588.
@article{ddc8e14c202a4d4eb4c50205b2908260,
title = "A novel flow through diffusion cell for assessing drug transport across the buccal mucosa in vitro",
abstract = "A novel flow through (FT) diffusion cell for assessing the permeability of compounds across the buccal mucosa was designed. porcine buccal mucosa was mounted between two chambers with flow through capacity in both the donor and receptor chambers. The permeability of caffeine (CAF), triamcinolone acetonide (TAC), and estradiol was determined over 4 h and flux values were compared to those obtained using a modified Ussing chamber (MUC). No significant differences in the flux of each probe compound were observed using either the MUC or the novel FT cell. The design of the FT cell allowed for monitoring appearance of receptor solution within the donor chamber during the initial equilibration period, allowing for visual inspection of tissue integrity. These permeability studies demonstrate that this FT cell is a suitable alternative model for assessing drug permeability across the buccal mucosa, without the limitations associated with the static MUC. This novel model was then utilized to determine whether salmeterol xinafoate (SX) could permeate the buccal mucosa at concentrations expected in the oral cavity following inhalation. Concentration-dependent studies demonstrated that SX permeates the buccal mucosa via passive diffusion and that oral mucosal absorption may contribute significantly to the overall systemic exposure of inhaled SX.",
author = "Lestari, {Maria Lucia Ardhani Dwi} and Joseph Nicolazzo and Finnin, {Barrie Charles}",
year = "2009",
language = "English",
volume = "98",
pages = "4577 -- 4588",
journal = "Journal of Pharmaceutical Sciences",
issn = "0022-3549",
publisher = "Elsevier",
number = "12",

}

A novel flow through diffusion cell for assessing drug transport across the buccal mucosa in vitro. / Lestari, Maria Lucia Ardhani Dwi; Nicolazzo, Joseph; Finnin, Barrie Charles.

In: Journal of Pharmaceutical Sciences, Vol. 98, No. 12, 2009, p. 4577 - 4588.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - A novel flow through diffusion cell for assessing drug transport across the buccal mucosa in vitro

AU - Lestari, Maria Lucia Ardhani Dwi

AU - Nicolazzo, Joseph

AU - Finnin, Barrie Charles

PY - 2009

Y1 - 2009

N2 - A novel flow through (FT) diffusion cell for assessing the permeability of compounds across the buccal mucosa was designed. porcine buccal mucosa was mounted between two chambers with flow through capacity in both the donor and receptor chambers. The permeability of caffeine (CAF), triamcinolone acetonide (TAC), and estradiol was determined over 4 h and flux values were compared to those obtained using a modified Ussing chamber (MUC). No significant differences in the flux of each probe compound were observed using either the MUC or the novel FT cell. The design of the FT cell allowed for monitoring appearance of receptor solution within the donor chamber during the initial equilibration period, allowing for visual inspection of tissue integrity. These permeability studies demonstrate that this FT cell is a suitable alternative model for assessing drug permeability across the buccal mucosa, without the limitations associated with the static MUC. This novel model was then utilized to determine whether salmeterol xinafoate (SX) could permeate the buccal mucosa at concentrations expected in the oral cavity following inhalation. Concentration-dependent studies demonstrated that SX permeates the buccal mucosa via passive diffusion and that oral mucosal absorption may contribute significantly to the overall systemic exposure of inhaled SX.

AB - A novel flow through (FT) diffusion cell for assessing the permeability of compounds across the buccal mucosa was designed. porcine buccal mucosa was mounted between two chambers with flow through capacity in both the donor and receptor chambers. The permeability of caffeine (CAF), triamcinolone acetonide (TAC), and estradiol was determined over 4 h and flux values were compared to those obtained using a modified Ussing chamber (MUC). No significant differences in the flux of each probe compound were observed using either the MUC or the novel FT cell. The design of the FT cell allowed for monitoring appearance of receptor solution within the donor chamber during the initial equilibration period, allowing for visual inspection of tissue integrity. These permeability studies demonstrate that this FT cell is a suitable alternative model for assessing drug permeability across the buccal mucosa, without the limitations associated with the static MUC. This novel model was then utilized to determine whether salmeterol xinafoate (SX) could permeate the buccal mucosa at concentrations expected in the oral cavity following inhalation. Concentration-dependent studies demonstrated that SX permeates the buccal mucosa via passive diffusion and that oral mucosal absorption may contribute significantly to the overall systemic exposure of inhaled SX.

UR - http://www3.interscience.wiley.com/journal/122370997/abstract

M3 - Article

VL - 98

SP - 4577

EP - 4588

JO - Journal of Pharmaceutical Sciences

JF - Journal of Pharmaceutical Sciences

SN - 0022-3549

IS - 12

ER -